Abstract: The first example of abiocatalytic [2, 3] -sigmatropic rearrangement reaction involving allylic sulfides and diazo reagents (Doyle-Kirmse reaction) is reported. Engineered variants of sperm whale myoglobin catalyze this synthetically valuable C À Cb ond-forming transformation with high efficiency and product conversions across av ariety of sulfide substrates (e.g., aryl-, benzyl-, and alkyl-substituted allylic sulfides) and a-diazo esters.M oreover,t he scope of this myoglobin-mediated transformation could be extended to the conversion of propargylic sulfides to give substituted allenes. Active-site mutations proved effective in enhancing the catalytic efficiency of the hemoprotein in these reactions as well as modulating the enantioselectivity,resulting in the identification of the myoglobin variant Mb(L29S,H64V,V68F), whichi s capable of mediating asymmetric Doyle-Kirmse reactions with an enantiomeric excess up to 71 %. This work extends the toolbox of currently available biocatalytic strategies for the asymmetric formation of carbon-carbon bonds.
Biocatalytic transformations can provide key opportunities for the development of economical and sustainable processes for the synthesis and manufacturing of fine chemicals and pharmaceuticals. [1] Enzyme-catalyzed carbon-carbon bondforming reactions have traditionally involved the use of aldolases,t hiamine diphosphate-dependent enzymes, hydroxynitrile lyases,a nd terpene cyclases,w ith protein engineering providing am eans to expand the scope of these enzymes to non-native substrates. [2] More recently,e ngineered and artificial metalloenzymes have made possible other valuable C À Cbond-forming transformations,including olefin cyclopropanation, [3] Suzuki coupling, [4] Diels-Alder reactions, [5] Friedel-Crafts indole alkylation, [6] Wittig olefination, [7] and olefin metathesis. [8] Despite this progress,t he toolbox of biocatalytic systems useful for the construction of CÀCb onds remains limited when compared to synthetic methods.
Our laboratory and the Arnold group have recently reported the ability of heme-containing proteins such as myoglobin [3d,7,9] and P450, [3a-c] respectively,toengage a-diazo ester reagents in carbene-transfer reactions.Inparticular, we found that engineered variants of sperm whale myoglobin can provide highly active and selective biocatalysts for carbenemediated transformations such as olefin cyclopropanation, [3d] Y À Hc arbene insertion (Y = N, S), [9] and aldehyde olefination. [7] Thet ransition-metal-catalyzed reaction between allyl sulfides and ad iazo reagent (the Doyle-Kirmse reaction) [10] represents ap owerful method for the creation of new CÀC bonds,which has found application in the synthesis of various biologically active molecules. [11] This process involves areaction between the allyl sulfide and ametallo-carbenoid species, leading to the formation of as ulfur ylide,w hich undergoes a [2, 3] -sigmatropic rearrangement. [10c, 11] While several organometallic catalysts,i ncluding rhodium, [10b,12] copper, [12a-c,13] and cobalt [14] complexes,h ave proven useful for promoting this transformation, [15] the development of catalytically efficient and enantioselective variants of this reaction has proven very challenging.
[11b] Herein, we report the development of myoglobin-based biocatalysts capable of promoting asymmetric Doyle-Kirmse reactions with high catalytic efficiency across ab road panel of allylic and propargylic sulfide substrates and different a-diazoesters.
Initially,w ei nvestigated the activity of sperm whale myoglobin (Mb) in catalyzing the [2, 3] -sigmatropic rearrangement of allyl phenyl sulfide 1 in the presence of ethyl a- Table 1 : Myoglobin-catalyzed tandem sulfur ylide formation and [2, 3] sigmatropic rearrangement of phenyl allyl sulfide with EDA. [a] Entry Catalyst Deviation from s.r.c. %conv. [b] TON [c] 1W (Table S1 and Figure S2 in the Supporting Information). Va rying the pH between 6a nd 9h ad an egligible effect on Mb-dependent catalytic activity,whereas improved conversion was obtained with atwo-fold excess of EDA(55 %vs. 19 %with one equiv EDA). As observed for hemin, the Mb-catalyzed formation of 3 show no enantiomeric excess (< 1%ee), thus indicating that the native Mb scaffold is unable to exert any asymmetric induction during the reaction. In order to identify more-efficient and selective Mb-based biocatalysts for this reaction, we evaluated ap anel of engineered Mb variants containing one to three amino acid substitutions at the level of the five residues defining the distal cavity of the hemoprotein (Leu29, Phe43, His64, Va l68, Ile107;F igure S1). Previously,w ef ound that mutations at these positions can dramatically alter the activity and selectivity of Mb variants as carbene- [3d, 7, 9, 16] and nitrene- [17] transfer catalysts.U pon testing in the reaction with 1 and EDA, an umber of Mb variants with significantly improved catalytic activity compared to the wild-type protein were identified ( Figure S3 [12c, 13b,c,14] In addition, in contrast to the need for slow addition of the diazo reagent in Rh- [12a,d] and Cu-catalyzed [13a] reactions,t he Mb(L29S,H64V,V68F)-catalyzed reaction proceeds with excellent chemoselectivity,that is,without carbene dimerization, even upon direct mixing of the sulfide and diazo reactants.T ime-course experiments further showed that the biocatalytic formation of 3 occurs with an initial rate of 167 turnovers per minute (Table S2 ) and reaches completion within 30 min (Table 1, Entry 9). These kinetics also compare very favorably with those of organometallic catalysts,a nd in particular those involving Cu and Co complexes,f or which reaction times of 10-36 hours have been reported. [13b,c,14] Controlling the enantioselectivity of Doyle-Kirmse reactions has proven challenging (typically, < 10-50 % ee), ap henomenon that has been attributed to the difficulty of discriminating,using chiral catalysts,between the heterotopic lone pairs of the sulfide during attack on the metallocarbenoid species to yield ac hiral sulfur ylide, [12a, 13a,c, 14b] the stereochemical information of which is then readily transferred to the carbon atom during the bond-rearrangement process. [18] While the native Mb scaffold produces 3 in racemic form, moderate to good levels of enantioselectivity were obtained with some of the engineered Mb variants (Figure S3) . Importantly,the highly active Mb(L29S,H64V,V68F) variant also showed the highest degree of stereocontrol, yielding 3 with an enantiomeric excess (ee)o f7 1% (Figure S3) . Notably,M b(H64V,V68A) favors formation of the opposite enantiomeric product with 46 % ee (49 %conv., 490 TON).
To examine the substrate scope of Mb(L29S,H64V,V68F), variously substituted a-diazo esters and allyl sulfides were tested. As shown in Table 2 , quantitative or nearly quantitative conversions to the desired products 13-15 (94-99 %) were achieved when starting from 1 and diazo reagents such as tert-butyl (2b), cyclohexyl (2c), or benzyl (2d) a-diazoacetate.G ood to excellent conversions (57-99 %) were also obtained for reactions involving allyl phenyl sulfides with substituted phenyl rings (4-6)t og ive products [16] [17] [18] .N ext, the Mb(L29S,H64V,V68F)-catalyzed transformation of benzyl-(8-9)a nd alkyl-substituted allyl sulfides (10) (11) (12) i n the presence of EDAw as examined. Theh igh yields measured for 20 and 21 (78-93 %) indicate that benzylsubstituted allyl sulfides are also efficiently processed by the biocatalyst. Except for the poorly water-soluble octyl allyl sulfide (11) , moderate to high product conversions (35-86 %) were achieved for the reactions with other alkyl-substituted allyl sulfides (22, 24) , which further supports the broad substrate scope of Mb(L29S,H64V,V68F). Finally,t he successful synthesis of 19 from phenyl but-2-enyl sulfide (7)and EDA(> 99 %conv.) showed that substitutions at the level of the allyl group are also tolerated by the Mb variant. Under catalyst-limited conditions (i.e., using 0.01 mol %), Mb(L29S,H64V,V68F) was found to support thousands of catalytic turnovers (1000-8800) for all of the tested substrates except 11 ( Table 2) .
The [ 2, 3] -sigmatropic rearrangement of propargylic sulfides offers aconvenient route to generate allenes,which are valuable intermediates for ah ost of synthetic transformations. [19] To assess the scope of the Mb(L29S,H64V,V68F) Scheme 1. Mb(L29S,H64V,V68F)-catalyzed [2, 3] -sigmatropic rearrangement of propargylic sulfides.
catalyst in the context of this reaction, variously substituted phenyl propargylic sulfides in combination with ethyl or benzyl a-diazo-acetate as carbene precursors were tested (Scheme 1). Notably,t he corresponding allenyl-substituted sulfide products (28-31)w ere obtained in high yields (71-83 %) in most cases,t hereby demonstrating the functionality of the Mb-based catalyst in promoting the [2, 3] -sigmatropic rearrangement of propargylic sulfide substrates. Chiral GC/SFC analyses showed that Mb(L29S,H64V,V68F) exhibits moderate to good enantioselectivity (20-60 % ee)i nt he transformation of several of the allylic sulfide substrates of Table 2 . In comparison, biocatalytic transformation of the propargylic sulfides occurred with significantly reduced enantiocontrol (< 15 % ee;S cheme 1). These experiments also revealed that the degree of asymmetric induction can be influenced by the structure of the diazo reagent (e.g., 47-71 % ee for 3 and 15 vs.6-9 % ee for 13 and 14). Finally,al arger-scale reaction with 15 mg of phenyl allyl sulfide (1), 2equiv of EDA( 2a), and 0.1 mol % Mb(L29S,H64V,V68F) enabled the isolation of 19.4 mg of 3 in 84 %y ield, thus demonstrating the scalability of the biocatalytic process.
Scheme 2d epicts ap lausible mechanism for the Mbcatalyzed reaction reported herein. We envisage the initial formation of an iron-porphyrin-bound carbenoid species (II), which has electrophilic character [3d, 20] and can react with nucleophiles. [7, 9] Accordingly,nucleophilic attack through the action of the allylic sulfide on this intermediate is envisioned to give rise to asulfonium ylide (III), followed by arapid [2, 3] sigmatropic rearrangement to yield the final product. The proposed role of the sulfide substrate as an ucleophile is consistent with the experimentally observed higher reactivity of electron-rich allyl sulfides versus isosteric,electrodeficient counterparts (17 vs. 18;T able 2). This trend was reproduced with other Mb variants [e.g., 83-95 %conversion for 17 vs.13-30 %f or 18 with Mb(H64V,V68A) and Mb(F43V,V68F)], thus suggesting that the differential reactivity is largely driven by the electronic properties of the substrate rather than by the biocatalyst. Thee nantioselectivity-determining step in asymmetric Doyle-Kirmse reactions is generally assumed to be associated with formation of the (chiral) sulfonium ylide, [12a, 13a,c, 14b] an assumption based on the high degree of stereoretention observed during the rearrangement of in situ prepared optically active sulfonium ylides. [18, 21] Within this mechanistic framework, we envision two alternative,although not mutually exclusive,s cenarios by which enantiocontrol could be exerted by the engineered Mb catalysts:1 )by influencing the pre-attack orientation of the sulfide so that approach to the heme-carbene intermediate through one of the lone pairs on the sulfur atom is preferred, and/or 2) by dictating which face of the heme-bound carbenoid group is exposed to attack by the sulfide nucleophile,inanalogy to our proposed stereochemical model for Mb-catalyzed olefin cyclopropanation.
[3d]
While further studies are warranted to discriminate between these scenarios,e xperiments were performed to clarify the beneficial role of the active-site mutations in Mb(L29S,H64V,V68F). To this end, we characterized and compared the catalytic activity and selectivity of aset of single and double reversion mutants in the reaction with phenyl allyl sulfide (1)a nd EDA ( Table S2 ). In line with our previous observations, [3d, 9a, 16] mutation of the distal His residue (H64V) increases both the TTN (2230 vs.1 615 for Mb) and product formation rate (121 vs.79min À1 ), possibly through facilitating access of the substrate to the heme cavity ( Figure S1 ). The L29S mutation further enhances the catalytic competencyo f the hemoprotein, as suggested by the increased total turnovers (3085 TTN) supported by Mb(L29S,H64V). TheV 68F mutation has no beneficial effect when used alone or in combination with H64V,but it contributes synergistically with L29S to improving both TTN [6280 for Mb(L29S,H64V,V68F) vs.3 085 for Mb(L29S,H64V)] and rate (167 vs.1 18 min À1 ,r espectively). Interestingly,n one of the single-site or double-site variants showed significantly improved enantioselectivity compared to wild-type Mb (< 5% ee;T able S2). These results indicate that the enhanced enantioselectivity of Mb(L29S,H64V,V68F) stems from asynergistic contribution from the three active-site mutations.This effect is likely facilitated by the close proximity of these residues within the heme pocket (ca. 7 for C(b)···C (b) distance;F igure S1).
In summary,this study demonstrates that engineered Mb variants can serve as efficient biocatalysts for asymmetric Doyle-Kirmse reactions.W hen using the optimized variant Mb(L29S,H64V,V68F), good to excellent product conversions as well as high numbers of catalytic turnovers (up to 8820) were achieved across avariety of allylic and propargylic sulfides in the presence of a-diazo ester-based carbene precursors.I mportantly,t he enantioselectivity of the Mb catalyst could be tuned and optimized through mutations within the distal pocket of the protein. This work expands the toolbox of biocatalytic strategies for mediating sigmatropic rearrangements [22] and the asymmetric formation of carboncarbon bonds.
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